Concepedia

Martyn Wood

MW

Statistics

Publications

80

Citations

5.4K

H-Index

41

Active since

1981

Affiliations

Molecular Discovery (United Kingdom)(Current)

GlaxoSmithKline (United Kingdom)

New Frontier

UCB Pharma (Belgium)

GlaxoSmithKline (Italy)

Martyn Wood is an author at Molecular Discovery (United Kingdom) specializing in pharmacology, medicine, and neuropharmacology.

Publications per year

1981–2021

80

Publications

80

SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist

G.A. Kennett, Martyn Wood, Fiona Bright et al. · Neuropharmacology · 1997 · 524 citations · Full text

, , +12

Synthesis and Preclinical Evaluation of<sup>11</sup>C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain

Nabeel Nabulsi, Joël Mercier, Daniel Holden et al. · Journal of Nuclear Medicine · 2016 · 322 citations · Full text

, , +15

Pharmacological Actions of a Novel, High-Affinity, and Selective Human Dopamine D3 Receptor Antagonist, SB-277011-A

Stephen G. Taylor, Martyn Wood, Nigel Austin et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 288 citations · Full text

, , +16

<i>In vitro</i>and<i>in vivo</i>profile of SB 206553, a potent 5‐HT<sub>2C</sub>/5‐HT<sub>2B</sub>receptor antagonist with anxiolytic‐like properties

G.A. Kennett, Martyn Wood, Fiona Bright et al. · British Journal of Pharmacology · 1996 · 240 citations · Full text

, , +17

GABA<sub>B2</sub> Is Essential for G-Protein Coupling of the GABA<sub>B</sub> Receptor Heterodimer

Melanie J. Robbins, Andrew R. Calver, Alexander K. Filippov et al. · Journal of Neuroscience · 2001 · 209 citations · Full text

, , +17

1–5 of 80